YAM (DIOSCOREA ALATA) INHIBITS HYPERTRIGLYCERIDEMIA AND LIVER ENLARGEMENT IN RATS WITH HYPERCHOLESTEROL DIET
暂无分享,去创建一个
[1] Chen-Tien Chang,et al. Effects of Taiwanese yam (Dioscorea japonica Thunb var. pseudojaponica Yamamoto) on upper gut function and lipid metabolism in Balb/c mice. , 2003, Nutrition.
[2] Chen-Tien Chang,et al. Effects of Taiwanese yam (Dioscorea alata L. cv. Tainung No. 2) on the mucosal hydrolase activities and lipid metabolism in Balb/c mice , 2003 .
[3] Shih-Chang Lee,et al. Effects of "Chinese yam" on hepato-nephrotoxicity of acetaminophen in rats. , 2002, Acta pharmacologica Sinica.
[4] V. Vuksan,et al. Fiber in the Treatment of Hyperlipidemia , 2001 .
[5] D. Illingworth,et al. Management of hypercholesterolemia. , 2001, The Medical clinics of North America.
[6] J. Dietschy. Theoretical considerations of what regulates low-density-lipoprotein and high-density-lipoprotein cholesterol. , 1997, The American journal of clinical nutrition.
[7] M. Liebman,et al. Impact of different dietary fatty acids on plasma and liver lipids is influenced by dietary cholesterol in rats , 1996 .
[8] D. Klurfeld. CRC Handbook of Dietary Fiber in Human Nutrition, 2nd Ed. , 1994 .
[9] F. Parhami,et al. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. , 1993, The Journal of clinical investigation.
[10] R. Coleman,et al. Effect of diosgenin on biliary cholesterol transport in the rat. , 1993, The Biochemical journal.
[11] V. Ord,et al. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. , 1992, The American journal of pathology.
[12] D. Steinberg,et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[13] A. Goldberg,et al. Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing. , 1990, Atherosclerosis.
[14] A. J. Valente,et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[15] A. Lusis,et al. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins , 1990, Nature.
[16] M. Manjunath,et al. Chemical composition of mucilage of Chinese yam , 1990 .
[17] F. Sacks,et al. Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio. , 1989, The American journal of cardiology.
[18] J L Witztum,et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.
[19] M. H. Luria,et al. Effect of low-dose niacin on high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol ratio. , 1988, Archives of internal medicine.
[20] K. Uchida,et al. Changes in biliary and fecal bile acids in mice after treatments with diosgenin and beta-sitosterol. , 1984, Journal of lipid research.
[21] O. Onayemi,et al. PREPARATION AND STORAGE PROPERTIES OF DRUM DRIED WHITE YAM (Dioscorea rotundata Poir) FLAKES , 1974 .
[22] C. Demigné,et al. Low levels of viscous hydrocolloids lower plasma cholesterol in rats primarily by impairing cholesterol absorption. , 2000, The Journal of nutrition.
[23] B. McCrindle,et al. Effect of gemfibrozil in men with primary isolated low high-density lipoprotein cholesterol: a randomized, double-blind, placebo-controlled, crossover study. , 1993, The American journal of medicine.
[24] O. Onayemi. Some Chemical Factors Affecting the Quality of Processed Yam , 1986 .